AKT1 and acute myeloid leukemia: Constitutive activation of PI3K/Akt pathway promotes MDR phenotype in breast cancer (Clark et al, 2002), prostate cancer (Lee et al, 2004) and acute myeloid leukaemia (AML) (Grandage et al, 2005).